article = {JSO-2020-2-104}
title = {Painless Peri-Tonsillar Abscess in a Pediatric Patient: Case Report and Review of the Literature}
journal = {Journal of Surgical Oncology}
year = {2020}
issn = {2674-3000}
doi = {http://dx.doi.org/10.31487/j.JSO.2020.02.04}
url = {https://www.sciencerepository.org/painless-peri-tonsillar-abscess_JSO-2020-2-104 
author = {Christopher  Jabbour,Randa Barazi,}
keywords = {Crohn’s, Infliximab, Peri-tonsillar abscess}
abstract ={Crohn’s disease is an immune mediated inflammatory disease that affects the gastrointestinal tract anywhere
from the oral cavity proximally, to the anus distally. A large number of patients with Crohn’s disease may
present with a multitude of oropharyngeal manifestations, such as mucositis, granulomas and ulcerations.
Infliximab, a monoclonal antibody that binds to TNFα, is a treatment modality used in the management of
Crohn’s disease. 10% to 30% of patients with Crohn’s disease develop intra-abdominal abscesses in the
course of the disease, a finding that is much less common in oropharyngeal manifestations. We herein
present the case of a painless peri-tonsillar abscess in a patient with Crohn’s disease maintained on
infliximab that required surgical drainage as means of treatment. To our knowledge, this is the first case
demonstrating such a finding in a patient that is maintained on infliximab.}